waypoint wealth counsel Takes Position in Agilent Technologies, Inc. $A

waypoint wealth counsel bought a new stake in Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 1,902 shares of the medical research company’s stock, valued at approximately $224,000.

Several other institutional investors and hedge funds also recently made changes to their positions in A. Brighton Jones LLC grew its position in shares of Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares during the last quarter. GAMMA Investing LLC grew its position in shares of Agilent Technologies by 34.6% in the first quarter. GAMMA Investing LLC now owns 5,362 shares of the medical research company’s stock valued at $627,000 after purchasing an additional 1,379 shares during the last quarter. Assenagon Asset Management S.A. grew its position in shares of Agilent Technologies by 8.3% in the first quarter. Assenagon Asset Management S.A. now owns 30,827 shares of the medical research company’s stock valued at $3,606,000 after purchasing an additional 2,371 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its position in shares of Agilent Technologies by 86.3% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 51,363 shares of the medical research company’s stock valued at $6,009,000 after purchasing an additional 23,800 shares during the last quarter. Finally, Opal Wealth Advisors LLC acquired a new position in shares of Agilent Technologies in the first quarter valued at approximately $31,000.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on A. Rothschild Redb raised Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. Robert W. Baird upped their target price on Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research report on Thursday, August 28th. Barclays upped their target price on Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a research report on Thursday, October 2nd. UBS Group raised Agilent Technologies from a “neutral” rating to a “buy” rating and increased their price target for the stock from $130.00 to $170.00 in a research report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. increased their price target on Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $148.69.

Agilent Technologies Trading Down 2.5%

Shares of A stock opened at $136.62 on Monday. The stock’s fifty day moving average price is $125.04 and its two-hundred day moving average price is $117.02. The company has a market cap of $38.73 billion, a PE ratio of 32.07, a P/E/G ratio of 4.46 and a beta of 1.26. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.37. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company’s revenue was up 10.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be issued a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies’s dividend payout ratio (DPR) is currently 23.24%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.